window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : September 19, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Medical devices

  • Biotech & Pharma Business,Digital & Data,Medical devices,Therapeutic Areas

    Appleton blood centre adopts Reveos automation to boost platelet supply

    The Community Blood Center (CBC) in Appleton, Wisconsin has adopted [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Medical devices,Therapeutic Areas

    Neuraxpharm and mjn-neuro plan launch of digital solution for early detection of epileptic seizures

    Neuraxpharm and mjn-neuro are preparing to launch a digital health [...]

    May 5, 2026
  • Digital & Data,Medical devices,Therapeutic Areas

    India continuous glucose monitoring market set for steady growth to 2035

    India’s market for continuous glucose monitoring (CGM) devices is expected [...]

    May 5, 2026
  • Drug Delivery & Formulation,Drug Discovery & Development,Medical devices,Pharmaceuticals and therapeutics

    ACG wins Red Dot Design Award for personalised medicine concept

    ACG, a leading provider of solid-dosage solutions, has received the [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Drug Discovery & Development,Medical devices,Pharmaceuticals and therapeutics

    Paris-based Tulyp Medical seeks FDA clearance following initial clinical use of perfusion device

    Tulyp Medical, a Paris-based medtech startup, has emerged from stealth [...]

    May 5, 2026
  • Central Nervous System,Clinical & Regulatory,Drug Discovery & Development,Medical devices,Pharmaceuticals and therapeutics

    Owlstone Medical awarded up to $49.1 million from ARPA-H to develop at-home multi-cancer early detection tests

    Owlstone Medical has received an award of up to $49.1 [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Drug Discovery & Development,Medical devices,Pharmaceuticals and therapeutics

    Xeltis reports positive EU key trial results for aXess, showing superior patency and safety in hemodialysis

    Xeltis’ aXess EU key trial shows sustained patency, fewer interventions, [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Drug Discovery & Development,Medical devices,Opinion & Events,Pharmaceuticals and therapeutics,Therapeutic Areas

    Hansa Biopharma reports statistically significant improvement in kidney function, supporting planned BLA submission

    Hansa Biopharma AB has announced positive topline results from the [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Medical devices,Pharmaceuticals and therapeutics,Therapeutic Areas

    Xeltis poised for commercialization following positive EU pivotal trial results

    Xeltis has announced successful clinical data from its aXess EU [...]

    May 5, 2026
  • Biotech & Pharma Business,Manufacturing & Supply Chain,Medical devices,Pharmaceuticals and therapeutics

    Avingtrans posts record revenues as energy division drives growth

    Avingtrans Plc has reported record revenues of £156.4 million for [...]

    May 5, 2026
Previous678Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Kazia reports 83% response rate for paxalisib in triple-negative breast cancer
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
  • $3M funding targets tau-driven neurodegenerative diseases
    Categories: Central Nervous System, Drug Discovery & Development, Research & Development, Therapeutic Areas
  • Cancer vaccine research secures $2.5M NIH award for nanoparticle treatment
    Categories: Drug Delivery & Formulation, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top